Home›Stock Screener›Zenith Health Care

Zenith Health Care Share Price Today | Stock Price & Zenith Health Care Share Screener

ZENITHHE Pharmaceuticals & Biotechnology
Live Share Price BSE
₹3.15
▲ 0.00 (0.00%)
2026-11-19 00:00:00

As of November 19, 2026, the live Zenith Health Care share price (BSE: ZENITHHE) is ₹3.15, unchanged from the previous close, with shares trading between ₹3.11 and ₹3.21 in today's trading session, and a 52-week range of ₹2.42–₹3.89. Track Zenith Health Care networth to gauge the company's total market size. Use the Zenith Health Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Zenith Health Care opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Zenith Health Care Market Cap ₹17.27 Cr.
ZENITHHE P/E Ratio (TTM) -
Zenith Health Care P/B Ratio 2.34
EPS (TTM) -
Dividend Yield -
Debt to Equity -
ZENITHHE 52 Week High ₹3.89
Zenith Health Care 52 Week Low ₹2.42
Operating Margin -1.00%
Profit Margin -
ZENITHHE Revenue (TTM) ₹11.00
EBITDA -
Net Income -
Total Assets ₹11.00
Total Equity ₹7.00

Zenith Health Care Share Price Chart

Track the current stock price of Zenith Health Care with an interactive chart. Analyse ZENITHHE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Zenith Health Care stock quote in one place.

The quote of ₹3.15 sits between the 52-week low of ₹2.42 and the 52-week high of ₹3.89.

Zenith Health Care Company Profile - Fundamental Screener

Screen Zenith Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ZENITHHE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE812B01026.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE812B01026

Zenith Health Care Balance Sheet Screener

Screen ZENITHHE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹11, down from ₹11 in 2025.

Latest statistics put total assets at ₹11 and shareholder funds at ₹7.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 11 11 10 9 12 9 9 7 7 6
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 2 2 1 2 2 2 2 2 2 2

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 7 7 7 7 7 7 6 6 6 5
Share Capital 5 5 5 5 5 5 5 5 5 5
Reserves & Surplus 2 2 2 2 2 2 1 0 0 0

Zenith Health Care Income Statement Screener - Profit & Revenue Analysis

Screen Zenith Health Care income statement and profit fundamentals. Analyze ZENITHHE quarterly results. Zenith Health Care reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹11 and net profit was ₹0, at an operating margin of -1%.

In that period expenses were ₹11, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹11 and net profit of ₹0.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 11 11 12 15 14 23 14 12 10 10 5 4 4
Expenses 11 11 11 14 13 22 13 11 10 9 5 4 4

Operating Costs and Margins

EBITDA 0 0 1 1 0 1 1 1 0 1 0 0 0
Operating Profit % -1.00% -1.00% 1.00% 2.00% 0.00% 2.00% 3.00% 5.00% 2.00% 6.00% 1.00% -7.00% -1.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 0 0 0 0 1 1 1 0 0 0 -1 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 0 0 0 0 1 0 0 0 0 0
EPS 0.00 0.00 0.01 0.04 0.01 0.06 0.08 0.10 0.03 0.05 -0.03 -0.06 -0.05

Zenith Health Care Cash Flow Screener - Liquidity Fundamentals

Screen ZENITHHE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹1.

Over the same period, investing activities provided ₹1 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -1 1 2 -1 1 -2 2 0 0 0
Investing Activities 1 -1 -2 0 0 0 -1 0 0 0

Financing and Net Cash

Financing Activities 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 0 -1 1 -2 1 0 0 0

Zenith Health Care Shareholding Pattern Screener

See Zenith Health Care shareholding pattern with promoter, FII, and DII holdings. Check Zenith Health Care promoter holding and ownership changes for ZENITHHE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 28.74%, foreign institutions 0.00%, domestic institutions 0.39% and the public 63.94%, spread across 39,077 shareholders.

The shareholder count was 39,077 in 2026-Mar, compared with 38,725 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 28.74% 28.74% 28.74% 28.74% 28.74% 28.74% 28.74% 28.74%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 63.94% 63.92% 63.87% 64.12% 64.11% 64.08% 64.06% 64.08%
Other Holding 6.93% 6.95% 7.00% 6.75% 6.76% 6.79% 6.81% 6.79%
Shareholder Count 39,077 38,725 38,345 41,284 41,137 40,454 39,693 33,879

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Zenith Health Care. Zenith Health Care dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Zenith Health Care.

Zenith Health Care Stock Index Membership - Nifty & Sensex

See which indices include Zenith Health Care stock. Check ZENITHHE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Zenith Health Care is not part of any tracked indices.
Only major market indices are tracked in our system.

Zenith Health Care Market Events Screener - Corporate Actions

Get Zenith Health Care corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Zenith Health Care stock events that may affect ZENITHHE share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 28, 2026, with a record date of October 28, 2026.

It is followed by Annual General Meeting dated August 28, 2026 and Quarterly Result Announcement dated August 14, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-28 2026-10-28 Quarterly Result Announcement NA -1.31%
2026-08-28 2026-08-28 Annual General Meeting NA -2.56%
2026-08-14 2026-08-14 Quarterly Result Announcement NA -5.54%
2026-05-29 2026-05-29 Quarterly Result Announcement NA 2.52%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 0.60%
2025-11-11 2025-11-11 Quarterly Result Announcement NA 0.25%
2025-09-30 2025-09-30 Annual General Meeting NA -2.34%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -2.31%
2025-05-27 2025-05-27 Quarterly Result Announcement NA -3.00%
2025-02-11 2025-02-11 Quarterly Result Announcement NA 3.02%
2024-10-24 2024-10-24 Quarterly Result Announcement NA -3.57%
2024-08-26 2024-08-26 Annual General Meeting NA -2.82%

Zenith Health Care Competitors Screener - Peer Stocks Comparison

Screen ZENITHHE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,075 41.10 61,674 12.69% 11,565 63.60
Divis Laboratories 294,405 90.70 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 178,434 84.50 13,886 20.34% 2,138 47.27
Laurus Labs 122,375 98.10 6,868 22.01% 890 69.60
Zydus Life Science 119,172 27.60 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 115,344 41.70 35,059 3.90% 4,158 70.24
Cipla 112,656 39.40 29,045 2.24% 3,870 54.92
Mankind Pharma 108,920 48.40 14,636 14.85% 1,938 65.43
Aurobindo Pharma 104,586 26.40 34,145 5.56% 3,503 66.06
Lupin 90,301 17.30 29,039 26.75% 5,356 44.92

Zenith Health Care Company Announcements - News & Reports Screener

Screen ZENITHHE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 29, 2026.

The next most recent announcements are dated October 28, 2026 and October 28, 2026.

Date Update Actions
2026-10-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-28 Result-Unaudited- September 2026 -
2026-10-28 Board Meeting Outcome for Outcome Of Board Meeting -
2026-10-21 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday October 28 2026 -
2026-10-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-25 Closure of Trading Window -
2026-08-31 Retire By Rotation Of Mrs. Neela M. Raycha (DIN : 01258479) As A Non-Executive Director Of The Company -
2026-08-31 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-31 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-31 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-28 Proceedings Of 32Nd Annual General Meeting Held On 28Th August 2026 -
2026-08-28 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-19 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-14 Submission Of Financial Results For Quarter Ended June 30 2026 -
2026-08-14 Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On 14Th August 2026 -
2026-08-07 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday August 14 2026 -
2026-08-05 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-04 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-04 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-04 Reg. 34 (1) Annual Report. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹3.15, within a 52-week range of ₹2.42 to ₹3.89. The P/B ratio is 2.34. Market capitalisation stands at ₹17.27 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.